Equipmed Transitline XL Foldable Transit Wheelchair

Equipmed Transitline XL Foldable Transit Wheelchair

Marsoni

M251S

$198.00

Get it in 3 business days with 1 day shipping. Friday, May 29

Equipmed Transitline XL Foldable Transit WheelchairThe Equimed Transitline XL is a premium folding transport wheelchair with innovative features that make it the smart choice for caregivers seeking convenience, reliability, and comfort. Crafted with a sturdy powder coated steel frame, this wheelchair is built to last, boasting an impressive 114kg weight capacity. Designed for user comfort, the Equipmed Transport Wheelchair features swing up footrests for effortless access, extra wide 51cm seat, and

Easy Shipping

Quick Dispatch:

Your Equipmed Transitline XL Foldable Transit Wheelchair orders ship within 1-2 business days.

Delivery Options:

Standard: 3-7 business days
Fast: 2-3 business days
Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your Equipmed Transitline XL Foldable Transit Wheelchair ships.

Need Help?
Questions about Equipmed Transitline XL Foldable Transit Wheelchair, sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for Equipmed Transitline XL Foldable Transit Wheelchair in your area.

Get Shipping Estimates

Country Zip/Postal Code

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

These are very cute and so far my dog has not destroyed them and he’s a very aggressive chewer. They are great quality. The colors are vibrant. Rocky loves the squeaker. They're light weight and the perfect size . He enjoys playing with them. We like to take them when he’s not looking and throw them to watch him go fetch them.

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on June 3, 2026